Chao Qi

Person

Newark, DE, US

People

Patents Grantslast 30 patents

Information Patent Grant
Bicyclic heterocycles as FGFR inhibitors
- Patent number 12,083,124
- Issue date Sep 10, 2024
- Incyte Corporation
- Oleg Vechorkin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazole and triazole KRAS inhibitors
- Patent number 12,077,539
- Issue date Sep 3, 2024
- Incyte Corporation
- Chao Qi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination...
- Patent number 12,060,433
- Issue date Aug 13, 2024
- Incyte Corporation
- Horacio G. Nastri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused pyrazine derivatives as A2A / A2B inhibitors
- Patent number 11,999,740
- Issue date Jun 4, 2024
- Incyte Corporation
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline compounds as inhibitors of KRAS
- Patent number 11,939,328
- Issue date Mar 26, 2024
- Incyte Corporation
- Qinda Ye
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors
- Patent number 11,673,894
- Issue date Jun 13, 2023
- Incyte Corporation
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic heterocycles as FGFR inhibitors
- Patent number 11,607,416
- Issue date Mar 21, 2023
- Incyte Corporation
- Oleg Vechorkin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heterocycles as FGFR inhibitors
- Patent number 11,591,329
- Issue date Feb 28, 2023
- Incyte Corporation
- Oleg Vechorkin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic compounds as immunomodulators
- Patent number 11,339,149
- Issue date May 24, 2022
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused pyrazine derivatives as A2A / A2B inhibitors
- Patent number 11,161,850
- Issue date Nov 2, 2021
- Incyte Corporation
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolopyrimidine compounds and uses thereof
- Patent number 11,111,247
- Issue date Sep 7, 2021
- Incyte Corporation
- Oleg Vechorkin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic compounds as immunomodulators
- Patent number 10,800,768
- Issue date Oct 13, 2020
- Incyte Corporation
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
CD73 INHIBITOR AND A2A/A2B ADENOSINE RECEPTOR INHIBITOR COMBINATION...
- Publication number 20250059293
- Publication date Feb 20, 2025
- INCYTE CORPORATION
- Horacio G. Nastri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BICYCLIC HETEROCYCLES AS FGFR INHIBITORS
- Publication number 20250057852
- Publication date Feb 20, 2025
- INCYTE CORPORATION
- Oleg Vechorkin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 Inhibitors
- Publication number 20250041310
- Publication date Feb 6, 2025
- INCYTE CORPORATION
- Hui Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUINOLINE COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20240368152
- Publication date Nov 7, 2024
- INCYTE CORPORATION
- Qinda YE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS
- Publication number 20240360140
- Publication date Oct 31, 2024
- INCYTE CORPORATION
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS
- Publication number 20230357255
- Publication date Nov 9, 2023
- INCYTE CORPORATION
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BICYCLIC HETEROCYCLES AS FGFR INHIBITORS
- Publication number 20230338389
- Publication date Oct 26, 2023
- INCYTE CORPORATION
- Oleg Vechorkin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY COMPRISING AN FGFR INHIBITOR AND A KRAS INHIBITOR
- Publication number 20230226040
- Publication date Jul 20, 2023
- INCYTE CORPORATION
- Alejandro Amador Arjona
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NAPHTHYRIDINE COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20230174555
- Publication date Jun 8, 2023
- Gencheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUINOLINE COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20230144051
- Publication date May 11, 2023
- INCYTE CORPORATION
- Qinda YE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOLE AND TRIAZOLE KRAS INHIBITORS
- Publication number 20220306633
- Publication date Sep 29, 2022
- INCYTE CORPORATION
- Chao Qi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY COMPRISING A2A/A2B INHIBITORS, PD-1/PD-L1 INHIB...
- Publication number 20220233529
- Publication date Jul 28, 2022
- INCYTE CORPORATION
- Hui Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20220213090
- Publication date Jul 7, 2022
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20220194931
- Publication date Jun 23, 2022
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS
- Publication number 20220135570
- Publication date May 5, 2022
- INCYTE CORPORATION
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF
- Publication number 20220017521
- Publication date Jan 20, 2022
- INCYTE CORPORATION
- Oleg Vechorkin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED TRICYCLIC KRAS INHIBITORS
- Publication number 20210355121
- Publication date Nov 18, 2021
- INCYTE CORPORATION
- Wenyu ZHU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20210269434
- Publication date Sep 2, 2021
- INCYTE CORPORATION
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD73 INHIBITOR AND A2A/A2B ADENOSINE RECEPTOR INHIBITOR COMBINATION...
- Publication number 20210230294
- Publication date Jul 29, 2021
- INCYTE CORPORATION
- Horacio G. Nastri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 Inhibitors
- Publication number 20210205311
- Publication date Jul 8, 2021
- INCYTE CORPORATION
- Hui Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS
- Publication number 20210139485
- Publication date May 13, 2021
- INCYTE CORPORATION
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BICYCLIC HETEROCYCLES AS FGFR INHIBITORS
- Publication number 20210106588
- Publication date Apr 15, 2021
- INCYTE CORPORATION
- Oleg Vechorkin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20210107900
- Publication date Apr 15, 2021
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BICYCLIC HETEROCYCLES AS FGFR INHIBITORS
- Publication number 20210009582
- Publication date Jan 14, 2021
- INCYTE CORPORATION
- Oleg Vechorkin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF
- Publication number 20200095250
- Publication date Mar 26, 2020
- INCYTE CORPORATION
- Oleg Vechorkin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS
- Publication number 20200031835
- Publication date Jan 30, 2020
- INCYTE CORPORATION
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS
- Publication number 20190292188
- Publication date Sep 26, 2019
- INCYTE CORPORATION
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20190225601
- Publication date Jul 25, 2019
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20180179197
- Publication date Jun 28, 2018
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20180179202
- Publication date Jun 28, 2018
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Bicyclic heterocycles as FGFR inhibitors

Imidazole and triazole KRAS inhibitors

CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination...

Fused pyrazine derivatives as A2A / A2B inhibitors

Quinoline compounds as inhibitors of KRAS

Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors

Bicyclic heterocycles as FGFR inhibitors

Bicyclic heterocycles as FGFR inhibitors

Heterocyclic compounds as immunomodulators

Fused pyrazine derivatives as A2A / A2B inhibitors

Pyrazolopyrimidine compounds and uses thereof

Heterocyclic compounds as immunomodulators

Patents Applicationslast 30 patents

CD73 INHIBITOR AND A2A/A2B ADENOSINE RECEPTOR INHIBITOR COMBINATION...

BICYCLIC HETEROCYCLES AS FGFR INHIBITORS

Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 Inhibitors

QUINOLINE COMPOUNDS AS INHIBITORS OF KRAS

FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS

IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS

BICYCLIC HETEROCYCLES AS FGFR INHIBITORS

COMBINATION THERAPY COMPRISING AN FGFR INHIBITOR AND A KRAS INHIBITOR

NAPHTHYRIDINE COMPOUNDS AS INHIBITORS OF KRAS

QUINOLINE COMPOUNDS AS INHIBITORS OF KRAS

IMIDAZOLE AND TRIAZOLE KRAS INHIBITORS

COMBINATION THERAPY COMPRISING A2A/A2B INHIBITORS, PD-1/PD-L1 INHIB...

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS

PYRAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF

FUSED TRICYCLIC KRAS INHIBITORS

TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS

CD73 INHIBITOR AND A2A/A2B ADENOSINE RECEPTOR INHIBITOR COMBINATION...

Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 Inhibitors

IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS

BICYCLIC HETEROCYCLES AS FGFR INHIBITORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

BICYCLIC HETEROCYCLES AS FGFR INHIBITORS

PYRAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF

FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS

IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS